Jean-Louis Falco
Chief Executive Officer bij CliniGenetics SA
Profiel
Jean-Louis Falco is the founder of CliniGenetics SA. He is currently the Chairman at Aurex SAS and SAS Linerbenne.
Previously, he served as the Chief Executive Officer at Arteria SA (France) and as a Member-Supervisory Board at Bleecker SA. He graduated from Université Paris Dauphine-PSL.
Actieve functies van Jean-Louis Falco
| Bedrijven | Functie | Begin |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Chief Executive Officer | - |
| Aurex SAS | Chairman | - |
| SAS Linerbenne | Chairman | - |
Eerdere bekende functies van Jean-Louis Falco
| Bedrijven | Functie | Einde |
|---|---|---|
| Arteria SA (France) | Chief Executive Officer | - |
| BLEECKER | Director/Board Member | - |
Opleiding van Jean-Louis Falco
| Université Paris Dauphine-PSL | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLEECKER | Finance |
| Bedrijven in privébezit | 4 |
|---|---|
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Health Technology |
| Arteria SA (France) | Commercial Services |
| Aurex SAS | |
| SAS Linerbenne |
